IT'S EARLY, BUT SIGNIFICANT PROGRESS IS BEING MADE
Published Papers
Dr. Gutruf and his colleagues have published a number of academic papers. You can find links to some their work below.
Biosymbiotic platform for chronic long-range monitoring of biosignals in li
Wearable devices for continuous monitoring of biosignals: Challenges and o
Context-aware Electromagnetic Design for Continuously Wearable Biosymbiotic
Additional Articles and Papers on Google
Additional Articles and Papers on Orchid
Additional Articles and Papers on ResearchGate
Additional Articles and Papers at University of Arizona
Human Trials
Add a description about this category
First Item
Add a description about this item
Second Item
Add a description about this item
Third Item
Add a description about this item
Market Research
Add a description about this category
First Item
Add a description about this item
Second Item
Add a description about this item
Third Item
Add a description about this item
Commercialization
Add a description about this category
First Item
Add a description about this item
Second Item
Add a description about this item
Third Item
Add a description about this item
SleeveSense™ will be available upon FDA clearance, which is expected in 2027.
Senphonix is a Delaware C-Corp., with offices in Minnesota and Arizona. For more information, contact us at info@senphonix.com or 612-913-0607; or follow us on LinkedIn. Copyright © 2026 Senphonix, Inc. - All Rights Reserved. Logos and trademarks are the property of their respective owners. All quotes herein are drawn from anonymous responses to two MarketWise Advising ("MarketWise") national studies, commissioned by Senphonix; some quotes were lightly edited for brevity.
This website uses cookies.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.